Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study

Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study

Background: The role of dysglycaemia as a risk marker for Pancreatic Ductal Adenocarcinoma (PDAC) is uncertain. We investigated the relationship between glycated haemoglobin (HbA1c) and incident PDAC using a retrospective cohort study within the UK Biobank. Methods: A study involving 499,804 partici...

Full description

Bibliographic Details
Main Authors: Declan McDonnell, Adrian W. E. Cheang, Sam Wilding, Sarah H. Wild, Adam E. Frampton, Christopher D. Byrne, Zaed Z. Hamady
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Cancers
Subjects:
pancreatic
adenocarcinoma
PDAC
diabetes
NODM
HbA1c
Online Access:https://www.mdpi.com/2072-6694/15/16/4078

Internet

https://www.mdpi.com/2072-6694/15/16/4078

Similar Items